(1)
Molnár, T.; Farkas, K.; Nyári, T.; Szepes, Z.; Nagy, F.; Wittmann, T. Frequency and Predictors of Loss of Response to Infliximab or Adalimumab in Crohn’s Disease After One-Year Treatment Period – A Single Center Experience. JGLD 2012, 21, 265-269.